Stockreport

Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF Sachs analyst Andrea Tan from issuing a sunny outlook, raising her price target for the stock from $19 to $21. Given that it trades for around $17 at recent prices, Tan' [Read more]